Section 54-1739 - PROSPECTIVE DRUG REVIEW AND COUNSELING(1) Before dispensing any new prescription, a pharmacist shall complete a prospective drug review.(2) Before dispensing a prescription for a new medication, or when otherwise deemed necessary or appropriate, a pharmacist shall counsel the patient or caregiver. Counseling shall include such supplemental written materials as required by law or as are customary in that practice setting. For refills or renewed prescriptions, a pharmacist or a technician shall extend an offer to counsel the patient or caregiver. If such offer is accepted, a pharmacist shall provide such counseling as necessary or appropriate in the professional judgment of the pharmacist. All counseling and offers to counsel shall be face-to-face with the patient or caregiver when possible, but if not possible, then a reasonable effort shall be made to contact the patient or caregiver. Nothing in this section shall require a pharmacist to provide counseling when a patient or caregiver refuses such counseling or when counseling is otherwise impossible. Patient counseling shall not be required for inpatients of a hospital or institutional facility when licensed health care professionals administer the medication.(3) This section shall apply to all registered outlets.[54-1739, added 2011, ch. 263, sec. 2, p. 708; am. 2020, ch. 14, sec. 12, p. 49; am. 2021, ch. 54, sec. 28, p. 181.]Amended by 2021 Session Laws, ch. 54,sec. 28, eff. 7/1/2021.Amended by 2020 Session Laws, ch. 14,sec. 12, eff. 7/1/2020.Amended by 2011 Session Laws, ch. 263,sec. 2, eff. 7/1/2011.